Flyht Aerospace Solutions Ltd.: Invitation to the Q2 Virtual Investor Summit
Get Alerts FLY Hot Sheet
Join SI Premium – FREE
Calgary, Alberta--(Newsfile Corp. - May 17, 2021) - Flyht Aerospace Solutions Ltd. (TSXV: FLY) today announced that, Bill Tempany, Interim CEO, and Alana Forbes, CFO, will be attending the Q2 Virtual Investor Summit.
| Event | Q2 Investor Summit |
| Date | May 17-18th, 2021 |
| Presentation | May 18th at11:45 AM ET |
| Location | https://zoom.us/webinar/register/WN_5ogHcSbtR0m2SSAOKvv1AQ |
About Flyht Aerospace Solutions Ltd.
FLYHT provides airlines with Actionable Intelligence to transform operational insight into immediate, quantifiable action, delivering industry leading solutions to improve aviation safety, efficiency and profitability. This unique capability is driven by FLYHTs patented aircraft certified hardware products including AFIRS", a satcom aircraft interface device which enables real-time streaming of flight information, cockpit voice and black box data streaming and TAMDAR", which aggregates and streams airborne weather data in real-time. FLYHT is headquartered in Calgary, Canada with an office in Littleton, Colorado, and is an AS9100 Quality registered company.
For further information:
Flyht Aerospace Solutions Ltd.
Matt Chesler, CFA
646.809.2183
[email protected]
About the Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website atwww.investorsummitgroup.com
Contact:
Sasha Murray at [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Honey Badger Silver Announces Participation in the Canada Investment Summit and Provides Corporate Update
- Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial i
- NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Brings Solutions to Growing Challenges in Modern Warfare
Create E-mail Alert Related Categories
Newsfile, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share